RareKids-CAN Offer Subsidized Services for Investigator-initiated Academic Clinical Trials

RareKids-CAN offers a range of subsidized services for investigator-initiated (academic-led) pediatric rare disease clinical trials. The goal of these services is to stretch project funds further, ensuring greater impact and cost savings. Below is the list of subsidized services offered:

 

100% Subsidized Services (RareKids-CAN will cover 100% of the cost of the following services):

    • Consultations: We will conduct a robust consultation to identify areas of needs for your project with valuable involvement from relevant sub platforms based on your project needs to ensure your project receives adequate support.
    • High-level project management: An experienced project manager will ensure efficient coordination, oversight, and successful execution from inception to completion for your clinical trial.
    • Database build (not including management): We will provide project-specific electronic case report form (e-CRF) development and database management in a validated REDCap database housed at the Women and Children’s Health Research Institute (WCHRI).
    • Data Safety Monitoring Board: From our repository of individuals with specific expertise relevant to your project, we facilitate a centralized data safety monitoring board to ensure participant safety and provide expertise on clinical trial conduct for continuation, modification, or termination.

 

50% Subsidized Services (RareKids-CAN will cover 50% of the total cost of the following services):

    • Regulatory submissions: We assist study teams in the preparation and submission of clinical trial applications, investigational testing authorizations, and single-patient study applications for regulated clinical trials to Health Canada. We will also assist in adverse event reporting.
    • Monitoring: We have a dedicated and experienced monitoring team to perform risk-based remote and on-site monitoring to meet the Health Canada required sponsor obligations.

All other services are 100% cost recovered (i.e., RareKids-CAN will not subsidize)

 

If you have a clinical trial that require these services or would like to further discuss, you can complete the project intake form.

RareKids-CAN logo

Read next...

CIHR logo

Emerging Leaders Webinar and Workshop Series from the CIHR-Institute of Musculoskeletal Health and Arthritis

The Emerging Leaders Series at CIHR-IMHA is designed to support learning and career development for a new generation of equitable and inclusive leaders in health research.

NMD4C launches 2024-2025 NNLS

NMD4C Launch Third Annual Training Series for Clinical Neuromuscular Fellows

The NMD4C Clinical Research Curriculum Development team is pleased to share that the third annual National Neuromuscular Lecture Series began this past August.

2025 clinical and research fellowships competition from NMD4C and MDC.

2025 NMD4C and MDC Neuromuscular Fellowship Funding Competition Opens

Together with MDC we are excited to announce the opening of our 2025 annual funding competition to award postdoctoral fellowships in NMD research, and clinical fellowship awards in neuromuscular medicine and electromyography! 

MDC-researchgrants-2025

MDC Translational Science and Clinical Research Grants Competition Opens for 2024-25

Muscular Dystrophy Canada’s annual Neuromuscular Research Grant Program invests in
projects related to the diagnosis, treatment, or clinical care of neuromuscular disorders.

Canada-reaches-100NBS_900px

100 percent of Canada is Now Screening Infants for Spinal Muscular Atrophy

We are excited to share that from August 20, 2024, all babies born in Canada can now be tested for spinal muscular atrophy (SMA), a potentially fatal neuromuscular disorder.

Western-Canadian-Neuromuscular-Conference

Western Canadian Neuromuscular Conference Accepting Scientific Abstracts for Research Symposium

Abstracts for the research symposium will be accepted until September 6, 2024. Please visit the WCNMC website for instructions on how to submit your abstract.